At close: December 16 at 9:14:29 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 3 | 16 | 15 |
| Avg. Estimate | 10.38M | 677.33k | 13.86M | 54.96M |
| Low Estimate | -- | -- | 1.5M | 15.83M |
| High Estimate | 74M | 2.03M | 75.55M | 164.6M |
| Year Ago Sales | 1.67M | 835k | 7.53M | 13.86M |
| Sales Growth (year/est) | 520.99% | -18.88% | 84.13% | 296.37% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KK3A.F | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/2/2024 |
| Reiterates | Needham: Buy to Buy | 12/2/2024 |
| Maintains | Mizuho: Outperform to Outperform | 11/21/2024 |
| Reiterates | Needham: Buy to Buy | 11/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/19/2024 |
Related Tickers
IKNA Ikena Oncology, Inc.
1.6100
-2.42%
BION.SW BB Biotech AG
36.00
-0.41%
GLPG.AS Galapagos NV
25.70
+1.50%
HLVX HilleVax, Inc.
1.9500
-0.51%
KZR Kezar Life Sciences, Inc.
6.58
-2.52%
GLPG Galapagos NV
26.91
+0.34%
IPSC Century Therapeutics, Inc.
1.1700
-4.10%
IMVT Immunovant, Inc.
27.63
+5.14%
DYN Dyne Therapeutics, Inc.
26.10
+1.44%
TIL Instil Bio, Inc.
22.50
+2.41%